Previous Article | Next Article ![]()
Journal of Bacteriology, October 2006, p. 7195-7204, Vol. 188, No. 20
0021-9193/06/$08.00+0 doi:10.1128/JB.00208-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Osmorégulation chez les bactéries, UMR CNRS 6026, Université de Rennes I, Campus de Beaulieu, Av. du Général Leclerc, 35042 Rennes, France,1 Biology Department, Building 68, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139-43072
Received 7 February 2006/ Accepted 21 June 2006
|
|
|---|
|
|
|---|
In S. meliloti, the catabolism of glycine betaine proceeds by successive demethylations that lead to glycine (38) (Fig. 1). The first step is catalyzed by betaine homocysteine methyl transferase (BHMT), which transfers a methyl group from glycine betaine to homocysteine, yielding methionine and dimethylglycine (DMG). Subsequent catabolism of DMG leads to the end product glycine (Fig. 1). To date, this is the only glycine betaine catabolic pathway that has been described in S. meliloti. Repression of this degradative pathway in hyperosmotic media allows glycine betaine to accumulate (38). BHMT-dependent catabolism of glycine betaine is widespread in nature and constitutes an important pathway for methionine synthesis in the kidney and liver (10). While the existence of BHMT activity has been suspected in many bacteria, the corresponding gene has never been identified; all the studies of betaine catabolism in bacteria have concerned only dimethylglycine and sarcosine catabolism (26, 41). The only glycine betaine transmethylase to have been described in a bacterium was identified in Pseudomonas aeruginosa (36), but it does not share any homology with mammalian BHMT proteins.
![]() View larger version (16K): [in a new window] |
FIG. 1. Methionine
biosynthesis in S. meliloti. The probable methionine
biosynthetic pathway as annotated previously
(http://bioinfo.genopole-toulouse.prd.fr/annotation/iANT/bacteria/rhime/)
is shown. MetA, homoserine O-succinyltransferase;
MetB, cystathionine gamma-synthase; MetC,
cystathionine beta-lyase; MetH, 5-methyltetrahydrofolate-homocysteine
methyltransferase; BHMT, betaine-homocysteine methyl transferase, as
proposed in this study. M-THF represents
methyltetrahydrofolate.
|
In this study, we analyzed the production of methionine in S. meliloti strain 102F34, searched for genes required for the putative pathways in the S. meliloti genome, made mutants defective in these pathways, and analyzed the phenotypes of the mutants. We confirmed that MetH is the only methionine synthase expressed in free-living S. meliloti strain 102F34 and identified the first bacterial gene encoding a protein related to mammalian BHMT.
|
|
|---|
(17) and SM10
(37). For growth
investigations, S. meliloti was grown aerobically in complex
medium MSY (29) or
minimal medium (3) at
30°C to an optical density at 570 nm of 1.5 to 1.8, prepared,
and inoculated in minimal lactate aspartate salts (LAS) medium
(33) as previously
described (16). The
minimal medium described by Vincent
(46) was used for the
BHMT assay. E. coli strains were grown aerobically in LB
medium (27) at
37°C. For the selection of E. coli strains, ampicillin
and kanamycin were added at 50 µg/ml and tetracycline at 10
µg/ml. For the selection of S. meliloti strains,
streptomycin was used at 100 µg/ml, kanamycin at 50
µg/ml, and tetracycline at 5
µg/ml. DNA manipulations and analysis. Chromosomal and plasmid DNA isolation and manipulations were carried out according to standard procedures (2, 34).
Construction of metH and bmt mutants.
DNA fragments located within the
coding regions of metH (from bases 1614 to 2431) and SMc04235
(from bases 183 to 866) open reading frames
(http://sequence.toulouse.inra.fr/meliloti.html)
were amplified by PCR using the oligonucleotides metH1
(5'-GAATATCTTCGCGGTCGC-3') and
metH2 (5'-TTCGAGGATCTTAGCCGAG-3')
for metH and bhmt1
(5'-GCCGACATCATTCTCACC-3') and
bhmt2 (5'-AGATGGTTGCAGGAGGTG-3')
for SMc04235. The PCR products were introduced into the pCR2.1 Topo
(Invitrogen) vector and subsequently transferred into the mobilizable
plasmid pVO147 (30),
which is nonreplicative in S. meliloti. The resulting plasmids
were transferred into S. meliloti 102F34 Smr by
triparental mating, and recombinants were selected on
kanamycin-containing plates.
M12-mediated transductions of the
mutations into the parental strain were performed in order to ensure a
clean background.
BHMT assay. [methyl-14C]Glycine betaine (2.07 GBq mmol1) and [methyl-14C]DMSA (2.0 GBq mmol1) were obtained as previously described (32, 43). Cells were grown in Vincent medium to mid-exponential growth phase, collected by centrifugation (15,000 x g; 10 min), washed twice, resuspended in 10 mM phosphate buffer, pH 7.5, and permeabilized with toluene (1:100 [vol/vol]). [14C]Glycine betaine or [14C]DMSA (3 kBq) and homocysteine (7 mM) were added to 0.4 mg of proteins of cell extract in a final volume of 50 µl. The mixture was incubated overnight at 37°C and extracted with ethanol (80% vol/vol). The extract was dried under vacuum, resuspended in water, and then fractionated by two-dimensional chromatography, using phenol (80%) in the first dimension and butanol-acetic acid-H2O (12:3:5) in the second dimension. After chromatography, radioactive spots were visualized and quantified using an instant imager (Packard). Glycine betaine, methionine, DMG, and sarcosine were used as internal standards to identify the radioactive spots. They were visualized as previously described (43).
Uptake and intracellular fate of glycine betaine. The uptake and metabolism of [14C]glycine betaine were analyzed as described previously (16, 19, 43). Cells were grown in LAS medium containing 1 mM [14C]glycine betaine (0.2 MBq/mmol) in the presence or absence of 0.5 M NaCl. CO2 produced during growth was trapped on a strip of filter paper (0.5 by 3 cm) moistened with 30 µl of 5 M KOH. This filter was changed at each sampling time. At regular intervals, 1 to 2 ml of cell suspension was harvested by centrifugation (12,000 x g; 2 min). The pellets were immediately extracted with 80% ethanol as described previously (43). The radioactivities of the ethanol-soluble fraction, the ethanol-insoluble fraction, and CO2 were measured by scintillation counting. The ethanol-soluble fraction was analyzed by paper chromatography (43). In all cases, [14C]glycine betaine represented more than 90% of the total radioactivity of this fraction. The results are the means of at least three independent experiments, and the standard deviation was less than 10%.
Plant assays. Medicago sativa L. var. Europe (alfalfa) was used as a host plant for testing the nodulation and N2 fixation of S. meliloti strains. Surface-sterilized germinating seedlings were grown in test tubes on nitrogen-free Jensen broth medium (22). One-week-old plants were inoculated with 109 cells of 102F34 Smr or metH and bmt mutants. Plants were grown aerobically at room temperature. Four weeks postinoculation, the number of nitrogen-fixing nodules was assessed. Samples of nodules were randomly harvested and crushed in order to recover the bacteria and to ensure that the bacteria present inside the nodule were the inoculated strain and not revertants.
|
|
|---|
![]() View larger version (14K): [in a new window] |
FIG. 2. Phenotype
of the metH mutant. metH (A and B) and wild-type (C
and D) strains were grown in LAS medium (A and C) or in 0.5 M NaCl-LAS
medium (B and D). Growth was analyzed in regular medium (open squares)
or in medium supplemented with 1 mM methionine (open triangles), 1 mM
glycine betaine (closed circles), or 1 mM DMG (closed diamonds).
OD570, optical density at 570
nm.
|
In LAS medium containing 0.5 M NaCl, the metH mutant was unable to grow. Addition of methionine to this medium restored its growth. In contrast to what is observed in LAS medium (Fig. 2A), in the presence of 0.5 M NaCl, the addition of glycine betaine allowed faster growth of the metH mutant than that observed with methionine (Fig. 2B). A reasonable explanation for this phenomenon is that glycine betaine is not only utilized for methionine synthesis, but is also used as an osmoprotectant, as observed for the wild-type strain (Fig. 2D). These physiological observations suggest the presence of an efficient BHMT activity in 0.5 M NaCl LAS medium. A previous study had reported that high osmolarity in the growth medium decreased the activities of the enzymes involved in the degradation of glycine betaine (38), but it remained sufficient to enable continuous catabolism of glycine betaine in hyperosmotic media (43).
Identification of a BHMT-coding gene. The transfer of a methyl group from glycine betaine to homocysteine catalyzed by BHMT is not only an alternate way to complete methionine biosynthesis; it was described as the first step in glycine betaine degradation (38). Although no BHMT-encoding gene was annotated in the S. meliloti genome, BLAST analysis with the human BHMT sequence revealed that the protein encoded by the SMc04325 open reading frame showed 24% identity with the human BHMT (9). BLAST scanning of the SMc04325 sequence against microbial genomes revealed that it is highly homologous to the amino-terminal domain of the methionine synthase encoded by metH, as previously observed with mammalian BHMTs (8). In addition, 8 of 19 sequenced genomes of alphaproteobacteria carried an apparent ortholog of the Smc04325 protein. Although none of the Smc04325-related proteins have known functions, all of them had two Zn binding motifs identified in the human and rat enzymes [G(A/V)NC and GGCC] (6, 8, 13) at the same locations as in the human BHMT enzyme (Fig. 3). Similarly, the BHMT amino acids interacting with homocysteine (9) are also conserved at the same positions in all these proteins. In contrast, among the three amino acids interacting with glycine betaine in the crystal structure of human BHMT (9), only one amino acid was conserved at the same position in all of the proteins. Although these data suggest that SMc04325 encodes a BHMT, the lack of conservation of some glycine betaine-interacting amino acids could reflect differences in substrate utilization between the human and S. meliloti enzymes, as the former can use DMSP (25) while the latter is unable to do so (32).
![]() View larger version (74K): [in a new window] |
FIG. 3. Alignment
of bacterial BHMTs with the human enzyme. BLAST scanning of the
SMc04325 sequence against microbial genomes
(http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi)
allowed the identification of various putative bacterial BHMT-encoding
sequences. The corresponding proteins were aligned with human BHMT
using CLUSTALW
(http://www.ebi.ac.uk/clustalw/).
The amino acids interacting with homocysteine and glycine betaine and
zinc binding domains in human BHMT are boxed and annotated as HC, GB,
and Zn, respectively. Each organism is identified by a three-letter
code: Sme, Sinorhizobium meliloti; Mel, Mesorhizobium
loti MAFF303099; Sil, Silicibacter pomeroyi DSS-3
(Silicibacter sp. strain TM1040); Jan, Jannaschia sp.
strain CCS1; Rds, Rhodobacter sphaeroides 2.4.1; Prd,
Paracoccus denitrificans PD1222; Unc, uncultured
alphaproteobacterium EBAC2C11; Hsa, Homo sapiens. Asterisks
indicate amino acids identical in all sequences, colons indicate
conserved substitutions, and periods indicate semiconserved
substitutions.
|
![]() View larger version (8K): [in a new window] |
FIG. 4. Growth
of wild-type and bmt strains on glycine betaine as the carbon
and energy source. S. meliloti 102F34 (closed symbols) and the
bmt mutant (open symbols) were grown in minimal medium AS
supplemented with 10 mM of lactate (squares), glycine betaine
(circles), or DMG (triangles) as the carbon and energy source.
OD570, optical density at 570
nm.
|
![]() View larger version (60K): [in a new window] |
FIG. 5. BHMT
assay. BHMT assays were performed on bmt (A) and
wild-type (B) strains grown in Vincent medium to
mid-exponential growth phase. Reaction products were separated by
two-dimensional chromatography. The positions of spots corresponding to
glycine betaine (GB), DMG, methionine (met), and sarcosine are
indicated.
|
Growth of the bmt mutant is specifically inhibited in the presence of glycine betaine. Glycine betaine has different roles in S. meliloti; it can be used as a carbon and nitrogen source, a methionine precursor, or an efficient osmoprotectant. Consequently, the behavior of the bmt mutant was analyzed in LAS medium in the absence or in the presence of 0.5 M NaCl and various osmoprotectants. The bmt mutant grew as efficiently as its parental strain in LAS medium (Fig. 4). The growth of the wild-type strain was not affected by the addition of 1 mM glycine betaine to LAS medium (Fig. 2C). In contrast, the growth rate and the growth yield of the bmt mutant were severely reduced when 1 mM glycine betaine was added to LAS medium. As observed for the wild-type strain (Fig. 6A), addition of 0.5 M NaCl to the growth medium reduced the growth rate of the bmt mutant (Fig. 6B). While glycine betaine improved the growth of the wild-type strain (Fig. 6A), it exerted a strong inhibition of the growth of the bmt mutant when added to hyperosmotic medium (Fig. 6B).
![]() View larger version (17K): [in a new window] |
FIG. 6. Effects
of betaines on the growth of the bmt mutant. Wild-type
(A) and bmt mutant (B) strains were grown
in LAS medium lacking NaCl (open circles) or containing 0.5 M NaCl
(closed circles) or 0.5 M NaCl medium supplemented with 1 mM glycine
betaine (open triangles), 1 mM trigonelline (closed triangles), 1 mM HB
(open squares), or 1 mM DMSP (open diamonds). OD570, optical
density at 570
nm.
|
Growth inhibition by glycine betaine in the bmt strain is relieved by methionine. The inhibitory effect of glycine betaine on the growth of the bmt strain was relieved when methionine was added to LAS medium containing glycine betaine either in the presence or in the absence of 0.5 M NaCl. The growth pattern in LAS medium containing glycine betaine and methionine was identical to that observed in the absence of glycine betaine (Fig. 7A). In hyperosmotic media, growth inhibition in the presence of glycine betaine was also relieved by methionine supplementation (Fig. 7B), allowing improvement of the growth rate to a level identical to that of the wild-type strain (Fig. 6A). Addition of methionine to the hyperosmotic medium lacking glycine betaine did not improve growth. In order to analyze the defect induced by glycine betaine on the biosynthetic pathway of methionine, growth of the bmt mutant was monitored in 0.5 M NaCl medium containing 1 mM glycine betaine supplemented with the methionine precursor homocysteine (Fig. 7B). The addition of homocysteine had no effect on growth. Since only methionine supplementation allowed growth recovery, we conclude that glycine betaine affects the conversion of homocysteine to methionine by MetH. Therefore, glycine betaine affects either the production or the activity of MetH.
![]() View larger version (16K): [in a new window] |
FIG. 7. Influences
of glycine betaine and methionine on the growth of the bmt
mutant. The bmt mutant was grown in LAS medium lacking NaCl
(A) or containing 0.5 M of NaCl (B) without any
supplementation (open triangles) or in the presence of 1 mM glycine
betaine (open circles), 1 mM methionine (open squares), 1 mM glycine
betaine plus 1 mM methionine (closed diamonds), or 1 mM glycine betaine
plus 1 mM homocysteine (closed circles). The growth rates of the
bmt mutant in LAS medium were identical in the absence and in
the presence of 1 mM homocysteine. OD570, optical density at
570
nm.
|
![]() View larger version (26K): [in a new window] |
FIG. 8. Fate
of glycine betaine in the wild-type strain and the bmt mutant.
The wild type (A, B, C, and D) and the bmt mutant (E, F, G,
and H) were grown in LAS medium containing 1 mM [C14]glycine
betaine in the absence (diamonds) or in the presence (circles) of 0.5 M
NaCl. Growth was in the absence (closed symbols) or in the presence of
1 mM methionine (open symbols). Growth (A and E) was monitored, and
aliquots were periodically harvested and extracted in 80% ethanol. The
radioactivities remaining in the growth medium (B and F) and in the
ethanol-soluble fraction (C and G) and incorporated in insoluble
material (D and H) were quantified by scintillation counting.
OD570, optical density at 570
nm.
|
Glycine betaine resulted in drastic growth inhibition of the bmt mutant (Fig. 8E). The addition of methionine relieved this inhibition and allowed increased catabolism of glycine betaine in either LAS or hyperosmotic medium (Fig. 8). The behavior of glycine betaine in the presence of methionine (Fig. 8F to H) was identical to that observed with the wild-type strain (Fig. 8B to D), and external glycine betaine was depleted within the first 20 h of growth in LAS medium in both strains. Glycine betaine was actively catabolized in both strains, and its accumulation in stressed cells was abolished as soon as external glycine betaine was depleted from the medium.
These results showed that BHMT is not the sole pathway for glycine betaine catabolism in S. meliloti strain 102F34. At least one alternative pathway exists and can be detected in the bmt mutant when the medium is supplied with methionine.
Nodulation efficiency of the metH and bmt mutants. In various rhizobia, the formation of nitrogen-fixing nodules by methionine-deficient mutants is compromised unless methionine is provided to the plant growth medium (1, 24, 44, 45). Therefore, we analyzed the nodulation behavior of the metH and bmt mutants of S. meliloti 102F34. After 4 days of germination, Medicago sativa seedlings were inoculated with either the bmt or metH mutant strain or the 102F34 Smr parent and grown in nitrogen-deprived medium. Plants were visually screened for nodulation by observing the root system 4 weeks after bacterial inoculation. Nodulation was effective and efficient on plants inoculated with either of the mutants, as well as with the 102F34 parental strain. All plants which were inoculated with the wild-type or either of the mutant strains had green leaves and comparable numbers of effective nodules, whereas the uninoculated control plants were smaller, with yellow leaves. The numbers of pink nodules per root were similar in plants inoculated with any of the three strains. Bacteria from mutant-generated nodules were streaked on MSY plates and analyzed for kanamycin resistance, and their phenotypes were characterized. All the analyzed colonies had the phenotype of the mutant used for inoculation. Thus, N2-fixing nodules formed on alfalfa were due to infection by the metH or bmt mutants and not by revertants.
Plants were also inoculated with a mixture of the wild-type strain and the bmt or metH derivative. After 4 weeks, nodules were harvested and crushed to recover the bacteria on appropriate MSY medium, and the numbers of Kanr (mutant strains) and Kans (wild type strain) bacteria were determined. The ratio of bmt to wild-type bacteria isolated from nodules was identical to that used for inoculation. In contrast, when the metH strain was coinoculated with the wild-type strain in identical proportions, the number of metH colonies recovered from nodules was 4 orders of magnitude lower than that of the wild-type colonies. This proportion was not improved when the ratio of metH over the wild-type strain was increased in the inoculation mixtures. This observation clearly indicates that metH is required for the competitiveness of S. meliloti during the establishment of symbiosis with alfalfa.
|
|
|---|
MetH is not the sole pathway allowing methionine synthesis in S. meliloti. A previous study showed the existence of a BHMT (38), which allows glycine betaine to be used as the methyl donor for the last step in methionine bioynthesis (38). In this study, we have characterized the BHMT coding sequence (named bmt). Interestingly, BHMT of S. meliloti is related to the human BHMT and to the amino-terminal domain of MetH enzymes, which carries the Zn- and homocysteine-binding domains (8, 9, 12). While betaine methyl transferase activity has been suspected in many bacteria, the corresponding genes have never been characterized. A glycine betaine transmethylase that can carry out the last step in methionine synthesis has been identified in Pseudomonas aeruginosa (36). However, this protein has no homology with S. meliloti BHMT or S. meliloti MetH and no homolog exists in the S. meliloti strain Rm1021 genome. Conversely, a BLAST scan of the P. aeruginosa genome with the S. meliloti BHMT sequence revealed only the existence of MetH. Thus, P. aeruginosa and S. meliloti use distinct enzymes for glycine betaine demethylation. BLAST searches revealed the presence of bmt orthologs only in the genomes of some alphaproteobacteria (Mezorhizobium loti, Silibacter pomeroyi, Rhodobacter sphaeroides, Jannaschia sp. strain CCS1, Paracoccus denitrificans, and the uncultured alphaproteobacterium EBAC2C11).
Glycine betaine catabolism. Previous work on glycine betaine catabolism had suggested that only the BHMT pathway allowed glycine betaine catabolism in S. meliloti. The present work shows that the situation might be more complex, since glycine betaine catabolism was observed in vivo in bmt strains. Thus, another glycine betaine catabolic pathway exists in bmt strains, but this catabolic activity is reduced in hyperosmotic media. Methionine supplementation enabled improved glycine betaine catabolism and its utilization as a growth substrate. This was unexpected, since the bmt mutant possesses a wild-type copy of the metH gene. These observations suggest two conclusions: (i) glycine betaine compromises MetH activity in the bmt strain and (ii) the alternative glycine betaine catabolic pathway does not produce methionine.
Inhibition of MetH at the transcriptional and enzymatic levels by glycine betaine was documented in Aspergillus nidulans (21). When glycine betaine is provided to A. nidulans, BHMT is the preferred pathway for methionine supply (21). A similar phenomenon could exist in S. meliloti. The presence of glycine betaine has no consequences for the methionine supply when BHMT is functional, but in its absence, the rate of methionine synthesis appears to be reduced, as suggested by the reduction of the growth rate of the bmt mutant when glycine betaine was added to the growth medium. Inhibition of methionine synthesis was greater in media containing 0.5 M of NaCl. This is probably due to the increase of the intracellular concentration of glycine betaine in response to the hyperosmotic stress, leading to greater inhibition of MetH activity.
Our results suggest that MetH activity can be affected by the presence of glycine betaine in the growth medium, involving an efficient BHMT activity to provide the cell with methionine. Surprisingly, the mutant lacking BHMT activity was able to catabolize glycine betaine through an alternate catabolic pathway which remains to be characterized. However, to be optimal, this pathway requires the presence of methionine and therefore an efficient BHMT activity, as MetH is inhibited by the presence of glycine betaine. This suggests that the alternative pathway is not of minor importance for glycine betaine catabolism. In vivo glycine betaine catabolism through the alternative pathway is dependent on the functioning of BHMT.
Nodulation. Methionine synthesis has been described as being essential for efficient nodulation by various rhizobia. In S. meliloti strain Rmd201, metA/metZ, metE, and metF mutants are auxotrophic for methionine. They form ineffective nodules containing a reduced number of infected cells, in which the bacteria fail to undergo complete differentiation into bacteroids (1). Similar results have been described for some methionine auxotrophs of S. meliloti strain 104A14 (24), which formed ineffective nodules. The nodulation efficiencies of methionine auxotrophs of other rhizobia are also affected, as in the cases of a metZ mutant of Rhizobium etli (44) and a cysD derivative of Sinorhizobium sp. strain BR816 (40). In contrast, the cysG derivative of R. etli forms effective nodules (45). All these studies suggest that the plants provide low concentrations of methionine to the bacteria. Variations can be observed, depending on the plant-rhizobium model; the presence of other organic sulfur sources, like cysteine or glutathione, could allow growth inside the plant (45). All of these previous studies concerned mutants whose production of homocysteine was affected. Nodulation by metH mutants had not been analyzed previously.
S. meliloti 102F34 metH and bmt single mutants could proliferate in M. sativa and form effective nodules. This suggests that the plant provides the bacteria with a level of methionine that is sufficient for S. meliloti strain 102F34 or a methionine precursor like glycine betaine. The metH mutant had the ability to proliferate when glycine betaine was present in the growth medium; however, glycine betaine studies have shown that the plant does not provide glycine betaine, homobetaine, or DMSP to the bacteria (28). These compounds were not detected in M. sativa; stachydrine and trigonelline were the only two methylammoniums produced by M. sativa (28). Stachydrine and trigonelline can be used as growth substrates and as osmoprotectants by S. meliloti. The assimilation pathway of stachydrine does not require BHMT activity but uses another pathway that produces proline by two successive demethylations (7, 31). This pathway does not produce methionine, so it could not rescue a metH mutant. In the presence of trigonelline, MetH activity is not impaired in vitro. MetH activity is not expected to be inhibited by plant betaines and could allow growth of the bmt mutant within the plant. The absence of a glycine betaine supply and the noninhibition of MetH by plant betaines suggest that MetH is the main pathway for methionine synthesis during symbiosis.
Since the metH mutant had no obvious defect in nodulation, the plant must provide the bacteria with methionine. However, the amount of methionine supplied by the plant must be limiting, as we observed that a metH mutant competes extremely poorly against its wild-type strain when equally coinoculated onto the plant.
This work was supported in part by the Centre National de la Recherche Scientifique and the Ministère de la Recherche et de l'Education Nationale and in part by Public Health Service Grant GM31030 from the National Institutes of Health (NIH) to G.C.W. G.C.W. was also supported by an American Cancer Society Research Professorship and an HHMI Professorship. L.B. was supported by Region Bretagne and NIH.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»